Intrathecal morphine-3-glucuronide-induced nociceptive behavior via Delta-2 opioid receptors in the spinal cord

Takaaki Komatsu1, Soh Katsuyama2, Hiroshi Nagase3

  • 1Department of Pharmacology, Daiichi University of Pharmacy, 22-1 Tamagawa-cho, Minami-ku, Fukuoka, Fukuoka 815-8511, Japan; School of Pharmacy, Duquesne University, 600 Forbes Avenue, Pittsburgh, PA 15282, USA.

Insights

Morphine metabolite M3G causes scratching via dynorphin conversion to leucine-enkephalin (Leu-ENK), activating delta-2 opioid receptors and spinal ERK. Leu-ENK, not dynorphin, mediates M3G

Area of Science:

  • Neuroscience
  • Pharmacology
  • Pain Research

Background:

  • Morphine-3-glucuronide (M3G), a major morphine metabolite, lacks analgesic properties but induces nociceptive behaviors.
  • The precise mechanisms underlying M3G-induced neurotoxicity and pain signaling remain incompletely understood.

Purpose of the Study:

  • To elucidate the opioid receptor subtypes and downstream signaling pathways involved in M3G-induced behavioral responses and spinal cord activation.
  • To investigate the role of dynorphin metabolism and leucine-enkephalin (Leu-ENK) in M3G-induced nociception.

Main Methods:

  • Intrathecal (i.t.) administration of M3G in mice, followed by behavioral assessments (scratching, biting, licking).
  • Pretreatment with antisera against dynorphin and Leu-ENK, and opioid receptor antagonists (nor-BNI, naltrindole, naltriben, BNTX).
  • Assessment of ERK activation in the lumbar dorsal spinal cord using Western blotting.

Main Results:

  • M3G induced dose-dependent scratching, inhibited by antisera against dynorphin and Leu-ENK, but not the kappa-opioid antagonist nor-BNI.
  • Leu-ENK-converting enzyme inhibitors potentiated M3G-induced responses.
  • Delta-2 opioid receptor antagonists (naltrindole, naltriben) inhibited M3G effects, while delta-1 antagonist (BNTX) did not.
  • M3G activated spinal ERK, an effect blocked by Leu-ENK and delta-2 opioid receptor antagonists.

Conclusions:

  • M3G-induced nociceptive responses and spinal ERK activation are mediated by Leu-ENK, derived from dynorphin.
  • These effects are triggered via the activation of delta-2 opioid receptors in the spinal cord.

Related Concept Videos

Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
3.0K
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
1.5K
Nociception01:44

Nociception

Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain.
34.7K
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
6.5K
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
1.5K
Local Anesthetics: Clinical Application as Epidural Anesthesia01:29

Local Anesthetics: Clinical Application as Epidural Anesthesia

Epidural anesthetics are administered in the fat-filled epidural space, the outermost part of the spinal canal. This technique is commonly employed for pain management and anesthesia during lower abdomen and pelvis surgeries or labor and delivery.
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
962